Cureus · 2025
Acute Promyelocytic Leukemia in a Patient With Sickle Cell Hemoglobin D Disease: A Case Report.
Клинический случайСтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Bokhary Mahmoud, Turak Esra, Ibrahim Rehab, Rashed Aly, Abdelhadi Mohamed, Ozturk Cigdem, Sudha Shruti, Kaynar Leylagul, Fadel Elias
Аннотация
Myeloid neoplasms can occur in patients with sickle cell disease; however, the underlying connection between the two remains unclear. These neoplasms, along with other cancers such as female breast cancer and male genital cancer, may arise de novo or secondarily due to chronic inflammation associated with sickling crises. This chronic inflammation, and its downstream effects, may lead to cytogenetic aberrations that increase the risk of developing myeloid neoplasms. Another potential risk factor is hydroxyurea, a medication commonly used to reduce the frequency of sickling crises, with some reported cases of associated myeloid malignancies. To explore this possible link, we present a case of acute promyelocytic leukemia in a patient with sickle cell hemoglobin D disease who had never received hydroxyurea.